Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Oct;63(10):1300–1306. doi: 10.1136/ard.2003.013680

Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease

D Chen 1, J Lan 1, F Lin 1, T Hsieh 1, M Wen 1
PMCID: PMC1754751  PMID: 15361391

Abstract

Objective: To determine the type 1 T helper (Th1)/type 2 T helper (Th2) balance in the peripheral blood (PB) and pathological tissues of patients with active untreated adult onset Still's disease (AOSD).

Methods: The percentages of interferon γ (IFNγ)- and interleukin (IL)4-producing Th cells in the PB of 20 patients with active untreated AOSD, 20 patients with active rheumatoid arthritis (RA), and 20 healthy controls were determined by intracellular staining and flow cytometry. Serum levels of IL18 and soluble IL2 receptor were measured by enzyme linked immunosorbent assay. Levels of IFNγ and IL4 messenger (m) RNA expression were examined by real time quantitative polymerase chain reaction in biopsy specimens of evanescent rash and synovitis from 8 patients with AOSD.

Results: Significantly higher IFNγ-producing Th cells and Th1/Th2 ratio in PB were found in patients with AOSD than in healthy controls. Percentages of IFNγ-producing Th cells and Th1/Th2 ratio in PB correlated significantly with clinical activity score and serum IL18 levels in patients with AOSD. Increased ratio of Th1/Th2 cytokine transcripts was seen in the biopsy specimens of evanescent rash and synovitis from patients with AOSD compared with normal skin controls and patients with OA. Th cell cytokine pattern in PB and cytokine mRNA expression in synovium were similar for patients with AOSD and with RA. After 3 months' treatment, clinical remission was associated with a marked decrease in the percentages of cytokine-producing Th1 cells, but not of the Th2 cells.

Conclusion: A predominance of Th1 cytokine may precipitate the pathogenesis of AOSD.

Full Text

The Full Text of this article is available as a PDF (199.1 KB).

Figure 1.

Figure 1

Open in a new tab

 Flow cytometric dot plots of intracellular cytokine production in Th cells obtained from PB of (A) one represented patient with active untreated AOSD; (B) one patient with active RA; and (C) one HC after stimulation with PMA/ionomycin in the presence of brefeldin A. The figure in the quadrants denotes the percentage of cells expressing IFNγ or IL4 in CD4+ T cells. Mean percentages of (D) IFNγ-; (E) IL4-producing Th cells; and (F) the Th1 (IFNγ)/Th2 (IL4) ratio in Th cells obtained from the PB of patients with active untreated AOSD, active RA, and the HC. Horizontal bars indicate means. The p values are provided for comparison of these three groups.

Figure 2.

Figure 2

Open in a new tab

 The ratio of Th1 (IFNγ)/Th2 (IL4) mRNA expression in the biopsy skin (A) of evanescent rash from patients with AOSD (n = 8) and from normal controls (NC, n = 4), and in the biopsy synovium (B) of active synovitis from patients with AOSD (n = 6), of active synovitis from patients with RA (n = 6) and OA controls (n = 4) was analysed by the real time TaqMan PCR method. Data are presented as mean (SEM). The p values are provided for comparison of different groups.

Figure 3.

Figure 3

Open in a new tab

 Serum levels of IL18 in patients with active untreated AOSD, active RA, and healthy controls (HC). Horizontal bars indicate means. The p values are provided for comparison of the three groups.

Figure 4.

Figure 4

Open in a new tab

 Serial changes in (A) the levels of IL18 and sIL2R in serum, and in (B) the mean percentage of IFNγ-and IL4-producing Th cells in PB of 12 patients with AOSD before treatment and at 1 and 3 months after treatment with GC, NSAIDs, and methotrexate. Data are presented as mean (SEM).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amital H., Swissa M., Bar-Dayan Y., Buskila D., Shoenfeld Y. New therapeutic avenues in autoimmunity. Res Immunol. 1996 Jul-Aug;147(6):361–376. doi: 10.1016/0923-2494(96)82045-1. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Blaschke V., Reich K., Blaschke S., Zipprich S., Neumann C. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods. 2000 Dec 1;246(1-2):79–90. doi: 10.1016/s0022-1759(00)00304-5. [DOI] [PubMed] [Google Scholar]
  4. Bywaters E. G. Still's disease in the adult. Ann Rheum Dis. 1971 Mar;30(2):121–133. doi: 10.1136/ard.30.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cañete J. D., Martínez S. E., Farrés J., Sanmartí R., Blay M., Gómez A., Salvador G., Muñoz-Gómez J. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis. 2000 Apr;59(4):263–268. doi: 10.1136/ard.59.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cherwinski H. M., Schumacher J. H., Brown K. D., Mosmann T. R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med. 1987 Nov 1;166(5):1229–1244. doi: 10.1084/jem.166.5.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Constantin A., Loubet-Lescoulié P., Lambert N., Yassine-Diab B., Abbal M., Mazières B., de Préval C., Cantagrel A. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum. 1998 Jan;41(1):48–57. doi: 10.1002/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  9. De Carli M., D'Elios M. M., Zancuoghi G., Romagnani S., Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity. 1994;18(4):301–308. doi: 10.3109/08916939409009532. [DOI] [PubMed] [Google Scholar]
  10. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., Frucht D. M., Chrousos G. P., O'Shea J. J. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol. 2000 Feb 15;164(4):1768–1774. doi: 10.4049/jimmunol.164.4.1768. [DOI] [PubMed] [Google Scholar]
  11. Fujii T., Nojima T., Yasuoka H., Satoh S., Nakamura K., Kuwana M., Suwa A., Hirakata M., Mimori T. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 2001 Dec;40(12):1398–1404. doi: 10.1093/rheumatology/40.12.1398. [DOI] [PubMed] [Google Scholar]
  12. Gattorno M., Picco P., Vignola S., Stalla F., Buoncompagni A., Pistoia V. Serum interleukin 12 concentration in juvenile chronic arthritis. Ann Rheum Dis. 1998 Jul;57(7):425–428. doi: 10.1136/ard.57.7.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gibson U. E., Heid C. A., Williams P. M. A novel method for real time quantitative RT-PCR. Genome Res. 1996 Oct;6(10):995–1001. doi: 10.1101/gr.6.10.995. [DOI] [PubMed] [Google Scholar]
  14. Gracie J. A., Forsey R. J., Chan W. L., Gilmour A., Leung B. P., Greer M. R., Kennedy K., Carter R., Wei X. Q., Xu D. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest. 1999 Nov;104(10):1393–1401. doi: 10.1172/JCI7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoshino T., Ohta A., Yang D., Kawamoto M., Kikuchi M., Inoue Y., Kamizono S., Ota T., Itoh K., Oizumi K. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol. 1998 Feb;25(2):396–398. [PubMed] [Google Scholar]
  16. Huang J. L., Kuo M. L., Hung I. J., Wu C. J., Ou L. H., Cheng J. H. Lowered IL-4-producing T cells and decreased IL-4 secretion in peripheral blood from subjects with juvenile rheumatoid arthritis. Chang Gung Med J. 2001 Feb;24(2):77–83. [PubMed] [Google Scholar]
  17. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods. 1993 Feb 26;159(1-2):197–207. doi: 10.1016/0022-1759(93)90158-4. [DOI] [PubMed] [Google Scholar]
  18. Kawashima M., Yamamura M., Taniai M., Yamauchi H., Tanimoto T., Kurimoto M., Miyawaki S., Amano T., Takeuchi T., Makino H. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum. 2001 Mar;44(3):550–560. doi: 10.1002/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  19. Kusaba M., Honda J., Fukuda T., Oizumi K. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol. 1998 Aug;25(8):1466–1471. [PubMed] [Google Scholar]
  20. Lama Giuliana, Luongo Ilaria, Tirino Giuseppina, Borriello Adriana, Carangio Ciro, Salsano Maria Esposito. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis. 2002 May;39(5):958–965. doi: 10.1053/ajkd.2002.32769. [DOI] [PubMed] [Google Scholar]
  21. Maino V. C., Picker L. J. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry. 1998 Oct 15;34(5):207–215. doi: 10.1002/(sici)1097-0320(19981015)34:5<207::aid-cyto1>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  22. Micallef M. J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996 Jul;26(7):1647–1651. doi: 10.1002/eji.1830260736. [DOI] [PubMed] [Google Scholar]
  23. Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111–147. doi: 10.1016/s0065-2776(08)60652-5. [DOI] [PubMed] [Google Scholar]
  24. Ohta A., Yamaguchi M., Kaneoka H., Nagayoshi T., Hiida M. Adult Still's disease: review of 228 cases from the literature. J Rheumatol. 1987 Dec;14(6):1139–1146. [PubMed] [Google Scholar]
  25. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995 Nov 2;378(6552):88–91. doi: 10.1038/378088a0. [DOI] [PubMed] [Google Scholar]
  26. Ozen S., Tucker L. B., Miller L. C. Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokine staining. J Rheumatol. 1998 Aug;25(8):1651–1653. [PubMed] [Google Scholar]
  27. Prussin C., Metcalfe D. D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995 Dec 15;188(1):117–128. doi: 10.1016/0022-1759(95)00209-x. [DOI] [PubMed] [Google Scholar]
  28. Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S., Shevach E. M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med. 1994 Nov 1;180(5):1961–1966. doi: 10.1084/jem.180.5.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Raziuddin S., Bahabri S., Al-Dalaan A., Siraj A. K., Al-Sedairy S. A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function. Clin Immunol Immunopathol. 1998 Feb;86(2):192–198. doi: 10.1006/clin.1997.4457. [DOI] [PubMed] [Google Scholar]
  30. Reichert L. J., Keuning J. J., van Beek M., van Rijthoven A. W. Lymph node histology simulating T-cell lymphoma in adult-onset Still's disease. Ann Hematol. 1992 Jul;65(1):53–54. doi: 10.1007/BF01715128. [DOI] [PubMed] [Google Scholar]
  31. Ritchlin C., Haas-Smith S. A., Hicks D., Cappuccio J., Osterland C. K., Looney R. J. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998 Aug;25(8):1544–1552. [PubMed] [Google Scholar]
  32. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991 Aug;12(8):256–257. doi: 10.1016/0167-5699(91)90120-I. [DOI] [PubMed] [Google Scholar]
  33. Rooney M., David J., Symons J., Di Giovine F., Varsani H., Woo P. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol. 1995 May;34(5):454–460. doi: 10.1093/rheumatology/34.5.454. [DOI] [PubMed] [Google Scholar]
  34. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  35. Scheinberg M. A., Chapira E., Fernandes M. L., Hubscher O. Interleukin 6: a possible marker of disease activity in adult onset Still's disease. Clin Exp Rheumatol. 1996 Nov-Dec;14(6):653–655. [PubMed] [Google Scholar]
  36. Schulze-Koops H., Davis L. S., Haverty T. P., Wacholtz M. C., Lipsky P. E. Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. J Rheumatol. 1998 Nov;25(11):2065–2076. [PubMed] [Google Scholar]
  37. Schulze-Koops H., Lipsky P. E., Kavanaugh A. F., Davis L. S. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol. 1995 Nov 15;155(10):5029–5037. [PubMed] [Google Scholar]
  38. Scola Michael P., Thompson Susan D., Brunner Hermine I., Tsoras Monica K., Witte David, Van Dijk Marc A., Grom Alexei A., Passo Murray H., Glass David N. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol. 2002 Feb;29(2):369–378. [PubMed] [Google Scholar]
  39. Valente R. M., Banks P. M., Conn D. L. Characterization of lymph node histology in adult onset Still's disease. J Rheumatol. 1989 Mar;16(3):349–354. [PubMed] [Google Scholar]
  40. Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., Kashiwazaki S., Tanimoto K., Matsumoto Y., Ota T. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992 Mar;19(3):424–430. [PubMed] [Google Scholar]
  41. Yamamura M., Kawashima M., Taniai M., Yamauchi H., Tanimoto T., Kurimoto M., Morita Y., Ohmoto Y., Makino H. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum. 2001 Feb;44(2):275–285. doi: 10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  42. Yilmaz M., Kendirli S. G., Altintas D., Bingöl G., Antmen B. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Clin Rheumatol. 2001;20(1):30–35. doi: 10.1007/s100670170100. [DOI] [PubMed] [Google Scholar]
  43. van Roon J. A., Verhoef C. M., van Roy J. L., Gmelig-Meyling F. H., Huber-Bruning O., Lafeber F. P., Bijlsma J. W. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis. 1997 Nov;56(11):656–660. doi: 10.1136/ard.56.11.656. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES